Navigation Links
Aware, Inc. Reports First Quarter 2009 Financial Results
Date:5/6/2009

BEDFORD, Mass., May 5 /PRNewswire-FirstCall/ -- Aware, Inc. (Nasdaq: AWRE), a leading supplier of broadband technology and biometrics software, today reported financial results for its first quarter ended March 31, 2009.

Revenues for the first quarter of 2009 were $4.6 million, a decrease of 22% compared to $5.9 million in the same quarter last year.

The Company reports its net income and basic and diluted net income per share in accordance with U.S. generally accepted accounting principles (GAAP), and additionally, on a non-GAAP basis. Non-GAAP net income, where applicable, excludes the effect of stock-based compensation expense. The company uses the non-GAAP information internally to evaluate its operating performance and believes these non-GAAP measures are useful to investors as they provide additional insight into the underlying operating results. However, non-GAAP measures are not stated in accordance with, should not be considered in isolation from, and are not a substitute for, GAAP measures. A reconciliation of GAAP to non-GAAP results has been provided in the attached financial tables.

The GAAP net loss for the first quarter of 2009 was $2.1 million, or $0.09 per diluted share, which included $0.4 million of stock-based compensation charges in accordance with the provisions of FAS 123(R). This compared to a GAAP net loss of $1.3 million, or $0.05 per diluted share, for the same period a year ago.

The non-GAAP net loss for the first quarter of 2009, excluding the effect of stock-based compensation, was $1.7 million, or $0.07 per diluted share.

Michael Tzannes, Aware's chief executive officer, said, "We continued to experience slowdowns in our business as a result of the slowing economy during the first quarter. Our goal is to emerge from the current environment st
'/>"/>

SOURCE Aware, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology news :

1. Aware, Inc. Announces Final Results of Dutch Auction Tender Offer
2. Aware, Inc. Announces Q1 09 Earnings Conference Call
3. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
4. Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer
5. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
6. Aware, Inc. Commences Dutch Auction Tender Offer
7. Aware, Inc. Commences Dutch Auction Tender Offer
8. Aware, Inc. Reports Fourth Quarter and 2008 Financial Results
9. Sun Microsystems and Aware, Inc. Announce Integration of Awares BioSP with Sun Identity Management Solutions
10. Aware, Inc. Reports Fourth Quarter and 2007 Financial Results
11. Aware, Inc. Announces Richard Moberg to Return as CFO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/14/2014)... discovered a new kind of stem cell that can become ... blood vessels, according to a study published today in the ... a cell type contradicts current theory on how organs arise ... to origins of, and future treatment for, liver cancer., Thanks ... a complex being made up of more than 200 cell ...
(Date:10/14/2014)... Scientists from The Scripps Research Institute (TSRI) have been ... (NIH) to lead an investigation of Lassa fever virus, ... The study aims to understand how Lassa fever virus ... survive the inflection. , "The ultimate goal is ... Lassa fever virus causes disease and develop new treatments ...
(Date:10/14/2014)... team of researchers, led by the Chinese Academy of ... Nature Genetics a brief genomic history of tomato ... tomato plant. , The C.M. Rick Tomato Genetics Resource ... this study by providing seed of both cultivated tomato ... builds on the first tomato genome sequence completed just ...
Breaking Biology News(10 mins):Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 2Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 3Scripps Research Institute team receives $6.6 million to investigate deadly Lassa virus 2
... Sathyanaryanan Puthanveettil, an assistant professor on the Florida ... a pair of notable grants to study a critical ... receive $225,000 over three years from the prestigious Whitehall ... a motor protein called kinesin. In this study, he ...
... most commonly diagnosed cancer in the United States and often ... on ways to improve their understanding of the disease. ... at the San Diego Marriott Marquis & Marina during Jan. ... of Lung Cancer: Biology, Therapy and Personalized Medicine. ...
... WASHINGTON -- The draft 10-year strategic plan for ... shapes and coordinates climate and related global environmental change ... federal government -- is "evolving in the right direction," ... says a new report from the National Research Council. ...
Cached Biology News:Scripps Research Scientist wins pair of grants to study critical component of memory 2Lung cancer conference to focus on new diagnostic techniques, potential treatments 2New report reviews plan for US Global Change Research Program 2
(Date:10/22/2014)... Currently offering a comprehensive portfolio ... Weighing, Rice Lake, and Ohaus, Pipette.com has added ... Sartorius CPA Semi-Micro Balance is ideal for lab ... user-friendly laboratory balance. , Sartorius is a global ... balances are well known for their high performance, ...
(Date:10/22/2014)... 2014   Synthetic Biologics, Inc. (NYSE MKT: ... serious infections and diseases, announced today that the U.S. ... Allowance for a composition of matter patent application that ... program, SYN-004. This is Synthetic Biologics, first allowed patent ... adds to the Company,s extensive C. difficile ...
(Date:10/22/2014)... and HONG KONG , Oct. 22, ... therapeutics enterprise, announced today that rare disease expert ... vice president, research. Dr. McKew brings more than two ... positions at the National Institutes of Health, Wyeth Research ... Wyeth). Dr. McKew will lead aTyr,s efforts to expand and ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias Biotherapeutics, ... Company has signed a Notice of Grant Award ... (CIRM), effective October 1, 2014.  The NGA provides ... and the release of additional grant funds pursuant ... award for clinical development of Asterias, product, AST-OPC1. ...
Breaking Biology Technology:Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
... Genencor,s Senior Management Team, ROCHESTER, N.Y., Oct. ... announced that Dr. Glenn E. Nedwin will join ... effective Oct. 1, 2007. As a,member of the ... the,division,s activities in Grain Processing (which includes current ...
... CEO Glenn A. Oclassen to Join Sleep Experts in Panel Hosted by ... ... 1 Transcept Pharmaceuticals,Inc. today announced that Glenn A. Oclassen, President and ... the Natixis Bleichroeder "Hidden Gems" Healthcare Conference. Date: Monday, ...
... BRUSSELS, October 1 Austria now has the ... 2007 Euro,Health Consumer Index (EHCI). The EHCI compares ... Norway and Switzerland, from a,consumer-friendly point of view, ... 2005 winners the Netherlands, with 2006 winner,France in ...
Cached Biology Technology:Genencor Appoints New Executive Vice President - Technical Enzymes 2Transcept Pharmaceuticals to Participate in Middle-of-the-Night (MOTN) Insomnia Investor Panel 2European Union has 'Three-Speed' Healthcare System - Many Countries Lagging in Reform 2
Polyclonal Antibody to HADHB...
EDG-6 Lysate Source: Cell Lysate Application: Western Blotting Control Form: IgG...
Purified anti-Fanconi anemia D2-Phosphorylated (Ser222)...
A431 cells stimulated with EGF Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Biology Products: